US Broker Ratings

Cel-Sci Corporation (CVM) Investor Outlook: Unveiling a Massive 2,611% Potential Upside in Biotechnology

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors with its staggering potential upside of 2,611.07%, a figure that stands out in the high-stakes world..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Analyzing a 46.59% Potential Upside in Pediatric Orthopedic Innovation

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, particularly within the medical devices industry, as a unique player focused on pediatric orthopedic solutions. Headquartered..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 116% Potential Upside in Healthcare Innovation

Bioventus Inc. (NASDAQ: BVS), a key player in the medical devices sector, stands as a noteworthy investment candidate for those eyeing substantial growth potential within the..

Neuropace, Inc. (NPCE) Stock Analysis: Unlocking a Potential 69.88% Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) stands as a compelling opportunity, especially with a notable potential upside of..

Semler Scientific, Inc. (SMLR) Stock Analysis: Unpacking the 206% Potential Upside for Investors

Semler Scientific, Inc. (NASDAQ: SMLR) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $372.73 million, this..

Personalis, Inc. (PSNL) Investor Outlook: Navigating a Tumultuous Market with Innovative Genomic Solutions

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly in diagnostics and research, with its cutting-edge cancer genomic tests and services. Even as..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unlocking a 25% Upside with Robust Revenue Growth

For investors looking to tap into the healthcare sector’s promise, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling opportunity. This specialty pharmaceutical company is making significant..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem with Over 100% Potential Upside

Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is captivating investor attention with its innovative approach to gene and cell therapy. Headquartered in..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 74.83% Potential Upside in Healthcare Tech

Investors looking for opportunities in the health information services sector may want to consider Weave Communications, Inc. (NYSE: WEAV). With a market capitalization of $503.05 million,..

MeiraGTx Holdings plc (MGTX): Investor Outlook Reveals a Potential 215% Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its ambitious approach to genetic medicine. Specializing..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring a 246.85% Potential Upside in Biotechnology

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector for its promising portfolio of therapies targeting autoimmune diseases and..

Arvinas, Inc. (ARVN) Stock Analysis: Assessing an 81.27% Potential Upside in the Biotechnology Sector

Arvinas, Inc. (NASDAQ: ARVN) is a name that has been generating interest among investors, particularly in the healthcare sector, where innovation often leads to significant stock..

Septerna, Inc. (SEPN) Stock Analysis: A 12.84% Upside Potential in the Biotechnology Sector

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company based in South San Francisco, California, is garnering attention for its innovative approach in addressing critical healthcare challenges...

Trevi Therapeutics, Inc. (TRVI): Analyst Consensus Signals 84% Upside Potential

Investors eyeing the biotechnology sector may find Trevi Therapeutics, Inc. (NASDAQ: TRVI) a compelling prospect, particularly given the remarkable potential upside of 84.42% as identified by..

Fortrea Holdings Inc. (FTRE) Investor Outlook: Navigating Challenges and Opportunities in the Biotechnology Sector

Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology sector, with its robust focus on providing innovative solutions for biopharmaceutical product and medical device..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 98.97% Potential Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a U.S.-based biotechnology firm, has been generating buzz in the healthcare sector with its innovative approach to gene therapies targeting..

Valneva SE (VALN) Stock Analysis: Exploring a 45% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotech company, is making headlines in the healthcare sector with its strong revenue growth and promising pipeline of vaccines for..

CorMedix Inc. (CRMD) Stock Analysis: A 67% Upside Potential with Strong Buy Ratings

CorMedix Inc. (CRMD), a biopharmaceutical company based in Berkeley Heights, New Jersey, is drawing significant attention from investors in the biotechnology sector. Specializing in the development..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 53.80% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Boca Raton, Florida, the company..

Zenas BioPharma (ZBIO) Stock Analysis: Unpacking the 38.65% Potential Upside in the Biotech Space

Zenas BioPharma, Inc. (ZBIO) is capturing investor attention with its promising potential upside of 38.65%, according to recent analyst ratings. This clinical-stage biopharmaceutical company is making..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds